Market revenue in 2022 | USD 21.2 million |
Market revenue in 2030 | USD 32.7 million |
Growth rate | 5.6% (CAGR from 2022 to 2030) |
Largest segment | Blood culture media |
Fastest growing segment | Assay Kits & Reagents |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Blood culture media was the largest segment with a revenue share of 38.68% in 2022. Horizon Databook has segmented the Russia sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
There have been several developments in the country, which are contributing to the country’s market growth. For instance, in February 2022, an article published in ITMO University stated that researchers in Russia and Italy are developing optical sensors for early diagnosis of sepsis.
CNR Nanotec and ITMO University received funding from the Italian Ministry of Foreign Affairs and International Cooperation and the Russian Ministry of Science and Higher Education to develop this technology.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account